{"changeSha256":"30a593a71400b7ed19b568448c9391fb0089a2a2b6011a372b26a16e1807d92c","changedAt":"2026-11-15","changedFields":[{"after":"dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v10, fda-drugs-nda021318-2002-11-26-2f4c2df07e0a, fda-drugs-nda211939-2019-10-04-4790820cc8d4, fda-drugs-anda211097-2023-11-16-2855aa79a2e2, fda-drugs-nda218771-2024-06-04-4293d16697eb, fda-drugs-anda214412-2026-10-23-57b5e048e2bf","before":"dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9, fda-drugs-nda021318-2002-11-26-2f4c2df07e0a, fda-drugs-nda211939-2019-10-04-4790820cc8d4, fda-drugs-anda211097-2023-11-16-2855aa79a2e2, fda-drugs-nda218771-2024-06-04-4293d16697eb","field":"Cited source records"},{"after":"U.S. National Library of Medicine [sources: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v10]; U.S. Food and Drug Administration [sources: fda-drugs-nda021318-2002-11-26-2f4c2df07e0a]","before":"U.S. National Library of Medicine [sources: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9]; U.S. Food and Drug Administration [sources: fda-drugs-nda021318-2002-11-26-2f4c2df07e0a]","field":"Named organizations"},{"after":"name: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v10; aliases: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v10, fda-drugs-nda021318-2002-11-26-2f4c2df07e0a; category: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v10; status: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v10, fda-drugs-nda021318-2002-11-26-2f4c2df07e0a, fda-drugs-nda211939-2019-10-04-4790820cc8d4, fda-drugs-anda211097-2023-11-16-2855aa79a2e2, fda-drugs-nda218771-2024-06-04-4293d16697eb, fda-drugs-anda214412-2026-10-23-57b5e048e2bf; summary: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v10, fda-drugs-nda021318-2002-11-26-2f4c2df07e0a; evidenceNote: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v10","before":"name: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9; aliases: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9, fda-drugs-nda021318-2002-11-26-2f4c2df07e0a; category: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9; status: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9, fda-drugs-nda021318-2002-11-26-2f4c2df07e0a, fda-drugs-nda211939-2019-10-04-4790820cc8d4, fda-drugs-anda211097-2023-11-16-2855aa79a2e2, fda-drugs-nda218771-2024-06-04-4293d16697eb; summary: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9, fda-drugs-nda021318-2002-11-26-2f4c2df07e0a; evidenceNote: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9","field":"Claim citations"}],"currentVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/teriparatide/versions/4/","version":4},"id":"profile:teriparatide:v4","interpretationBoundary":"This event describes a PeptideScanner public-version change. It does not by itself establish that the cited source changed, that a scientific conclusion changed, or that source monitoring is continuous.","kind":"profile-updated","notice":"We moved this profile to the current DailyMed label (SPL version 10, published September 21, 2026), which adds a separate warning about allergic reactions, and added the October 23, 2026 Drugs@FDA approval of a further generic teriparatide application. The previous version, citing label version 9, remains available.","peptideSlugs":["teriparatide"],"previousChangeEvent":{"path":"/corrections/v1/profiles/teriparatide/v3.json","sha256":"28bdbd55c2ac9f6110b2111bf9a9f2d1e5e65cc47695a146357ad2709c59689e"},"previousVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/teriparatide/versions/3/","version":3},"schemaVersion":"peptidescanner-public-correction-lineage-event/v1","sourceRecords":[{"id":"dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v10","name":"DailyMed · U.S. National Library of Medicine","sourceClass":"A","title":"Teriparatide injection, solution · SPL version 10 · published 2026-09-21","url":"https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=d77d40db-7f38-88eb-fd5d-4282f0642028&version=10","verifiedAt":"2026-11-15"},{"id":"fda-drugs-anda214412-2026-10-23-57b5e048e2bf","name":"Drugs@FDA via openFDA","sourceClass":"A","title":"Drugs@FDA application ANDA214412 · original submission status AP · 2026-10-23 · dataset 2026-11-13","url":"https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22ANDA214412%22&limit=1","verifiedAt":"2026-11-15"}],"subject":{"slug":"teriparatide","type":"profile"}}
